Novo Nordisk A/S
ロング
更新済

$NVO expected have better second half (H2)

1 087
- Potential Inverse H&S on daily?
- In the worst case, NVO goes to 200 monthly moving average around $36
- Nonetheless, We are bottoming fundamentally only question is how fast the turn around gonna be.
ノート
- I had a very big position starting this year and but sold pre-earning when they unprofessionally released earnings on breakeven.

- I have bought back around 43.xx but not gonna build a massive position this time because I am afraid that turn around might be slower.
ノート
- There are blood in the streets so I want to build bigger position in other companies where turn around could be faster. However, I am buying NVO for long term as weightloss and well being is multi year secular trend
ノート
- NVO will still have better second half where it recovers.
- However, it's clear LLY is a superior drug and NVO latest results confirm it
トレード終了: ストップロスに到達
ノート
pre-market $42 ; I believe this is heading to 200 day monthly moving average around $36 and then might find support or bottom based on fundamentals
ノート
pre-market $42 ; I believe this is heading to 200 day monthly moving average around $36 and then might find support or bottom based on fundamentals
ノート
NVO as I mentioned probably has bottomed around 200 day monthly average around 35-36 bucks

免責事項

これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。